Insights

Growth momentum OncoLens has demonstrated rapid growth with Series A and Series B funding totaling at least $16 million in 2024, strong Inc. 5000 recognition, and ongoing leadership expansion, signaling a scalable opportunity to engage enterprise health systems and research networks seeking proven scale.

Healthcare AI focus The platform combines AI-driven analytics with multidisciplinary collaboration tools to improve patient outcomes and capture revenue opportunities, making it attractive to oncology programs looking to reduce patient leakage and accelerate access to trials and biomarker testing.

Strategic partnerships Existing and announced relationships with national cancer institutes, industry partners, and a Research Network indicate a ready-made pathway for co-development, real-world evidence projects, and expanded pilot programs within large cancer centers.

Tech stack readiness Utilizing modern cloud, data, and AI technologies (Google Cloud, OpenAI, Kubernetes, Redshift, Grafana, Auth0) supports enterprise-grade deployment and integration with hospital IT ecosystems, a selling point for security-conscious and data-driven buyers.

Revenue and expansion signals Reported revenue in the mid-range $25M-$50M with a growing customer base and leadership additions suggests a favorable buying window for larger health systems and academic centers seeking scalable analytics, trial matching, and workflow optimization capabilities.

Similar companies to OncoLens

OncoLens Tech Stack

OncoLens uses 8 technology products and services including Grafana, GitHub, Kubernetes, and more. Explore OncoLens's tech stack below.

Media & News

OncoLens's Email Address Formats

OncoLens uses at least 4 email formats:
OncoLens Email FormatsExamplePercentage
FirstLast@oncolens.comJohnDoe@oncolens.com
83%
FirLast@oncolens.comJohDoe@oncolens.com
11%
First@oncolens.comJohn@oncolens.com
5%
FirstLas@oncolens.comJohnDoe@oncolens.com
1%

Frequently Asked Questions

What is OncoLens's official website and social media links?

Minus sign iconPlus sign icon
OncoLens's official website is oncolens.com and has social profiles on LinkedIn.

How much revenue does OncoLens generate?

Minus sign iconPlus sign icon
As of October 2026, OncoLens's annual revenue is estimated to be $25M - $50M.

What is OncoLens's NAICS code?

Minus sign iconPlus sign icon
OncoLens's NAICS code is 62 - Health Care and Social Assistance.

How many employees does OncoLens have currently?

Minus sign iconPlus sign icon
As of October 2026, OncoLens has approximately 33 employees across 2 continents, including North America and Europe. Key team members include Director Of Enablement: D. O. and Software Engineer: S. D. S. Explore OncoLens's employee directory with LeadIQ.

What industry does OncoLens belong to?

Minus sign iconPlus sign icon
OncoLens operates in the Hospitals and Health Care industry.

What technology does OncoLens use?

Minus sign iconPlus sign icon
OncoLens's tech stack includes Grafana, GitHub, Kubernetes, Amazon Redshift, OpenAI, Auth0, Google Cloud and Salesloft.

What is OncoLens's email format?

Minus sign iconPlus sign icon
OncoLens's email format typically follows the pattern of FirstLast@oncolens.com. Find more OncoLens email formats with LeadIQ.

When was OncoLens founded?

Minus sign iconPlus sign icon
OncoLens was founded in 2017.
OncoLens logo

OncoLens

Hospitals and Health CareGeorgia, United States11-50 Employees

OncoLens is an oncology-focused digital health company in the Hospitals and Health Care industry, based in Atlanta, Georgia, United States, and employs between 11 and 50 people. The company provides a digital health platform that leverages AI-driven analytics and multidisciplinary collaboration tools to support cancer care by integrating both structured and unstructured data. Its platform aims to improve patient outcomes and capture revenue opportunities by preventing patient leakage and proactively identifying patients for clinical trials, biomarker testing, or other key services. Analytics capabilities are designed to help cancer centers and industry partners derive insights from patient cohorts, identify opportunities, and support quality improvement. OncoLens also operates the OncoLens Research Network, which collaborates with industry partners to bring curated research and real-world evidence initiatives to cancer centers, and in 2024 the company was recognized on Inc. 5000's fastest-growing list while pursuing financing rounds.

Section iconCompany Overview

NAICS Code
62 - Health Care and Social Assistance
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $25M - $50M

    OncoLens's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.